Michael Carney, MD, is an obstetrician/gynecologist in Honolulu, Hawaii. He is affiliated with Kapiolani Medical Center for Women & Children, The Queen’s Medical Center, and Maui Memorial Medical Center. Dr. Carney has extensive experience treating women for ovarian, cervical, and gynecological cancers. Prior to joining the Women’s Cancer Center and the John A. Burns School of Medicine, he worked at the prestigious Huntsman Cancer Institute. Dr. Carney completed both his obstetrics and gynecology residency and fellowship in gynecologic oncology at the Duke University Medical Center. He has developed clinical trials and is currently studying the molecular genetics of gynecological cancer to better understand and treat the disease.
Ryon K. Nakasone, MD, is a medical oncologist affiliated with the MD Anderson Cancer Network in Hawaii, largely practicing at the Kapiolani Medical Center for Women & Children, Kuakini Health System, and The Queen's Medical Center.
Jared D. Acoba, MD, graduated from the University of Hawaii Burns School of Medicine in 2001. He is a medical oncologist affiliated with the Kapiolani Medical Center For Women & Children, Kuakini Health System, and The Queen's Medical Center.
Shane Morita, MD, MS, PhD, FACS, is the surgical oncology program director at The Queen’s Medical Center/Queen’s Cancer Center and is part of the clinical faculty for the John A. Burns School of Medicine and the University of Hawaii Cancer Center. He is actively involved in program development for the Queen’s multidisciplinary cancer clinic and conducts research centered on molecular pathways and ethnic disparity of cancer in Hawaii, including thyroid carcinoma and cutaneous melanoma.
Additionally, Dr. Morita is the incoming Chair for the State of Hawaii Comprehensive Cancer Control Coalition and an active board member of the American Cancer Society Hawaii-Pacific chapter.
He has received numerous awards for his research and was the sole recipient of the NCCTG junior faculty grant from the Mayo Clinic.
Keola K. Beale, MD, was inspired to become an oncologist after losing both his father and grandfather to cancer during his medical training. An avid researcher, he enjoys participating in Kaiser Permanente's large oncology clinical trials program, and strives to communicate in a way that is both informative and empathetic—treating every patient as he would a loved one.
Kelly Shimabukuro, MD, is a member of several professional organizations, including the American Society of Clinical Oncology and the American Society of Hematology. Additionally, she has a background in HIV malignancies and served as a member of the AIDS Malignancy Consortium. At the International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies, Dr. Shimabukuro presented her clinical research on AIDS-associated Kaposi Sarcoma.
Susie Chen, MD, is a radiation oncologist affiliated with the Kapiolani Medical Center for Women & Children, Pali Momi Medical Center, and Straub Medical Center. She has extensive training in a variety of radiotherapy types, including low dose rate and high dose rate brachytherapy, nongynecologic brachytherapy, orthovoltage therapy, electron therapy, conventional stimulation, and 4D CT simulation.
Benjamin Falit, MD, JD, earned his medical degree from the Yale School of Medicine at Yale University in New Haven, Connecticut. After completing an internship in internal medicine at Yale New Haven Hospital, he trained at the Harvard Radiation Oncology Program in Boston, where he saw patients at Massachusetts General Hospital, Dana-Farber Cancer Institute, and Brigham and Women’s Hospital.
During medical school and residency, Dr. Falit won numerous awards related to both patient care and research. He is well-trained in the use of newer and more precise radiation delivery techniques, including intensity modulated radiation therapy, stereotactic radiosurgery, and stereotactic body radiation therapy. Dr. Falit has been an invited speaker on several panels related to healthcare policy and economics. He is board certified and a diplomat of radiation oncology by the American Board of Radiology.
Charles F. Miller, MD, served for 30 years in the U.S. Army Medical Department as Commander, 3rd Combat Support Hospital, Nuremberg. After retiring from active duty he completed nine years as chief of hematology-oncology at Kaiser Medical Center, Honolulu. He has served on the Hawaii Society of Clinical Oncology Board of Directors since 2002 and as president for seven of those years. He remains actively involved at the national level with the American Society of Clinical Oncology and holds a clinical appointment to the University of Hawaii Cancer Center. Dr. Miller presently serves on the University of Hawaii Cooperative Institutional Review Board as well as the Physicians Advisory Group to the Hawaii Health Information Exchange. He has been an active supporter of Compassion and Choices since 2012 and has worked as a member of Doctors for Dignity to support patient choice for end-of-life care for the people of the state of Hawaii.
Ian Okazaki, MD, is a medical oncologist affiliated with multiple hospitals in the Honolulu area, including Maui Memorial Medical Center and Pali Momi Medical Center. He received his medical degree from the University of Hawaii John A. Burns School of Medicine and has been in practice for more than 20 years.
David Tamura, MD, is a credentialed provider with MD Anderson Cancer Network, providing clinical care at The Queen's Medical Center in Hawaii. His areas of expertise include hematologic, gastrointestinal, and genitourinary malignancies. In addition to his clinical practice, he educates students and house staff from the University of Hawaii John A. Burns School of Medicine, and is actively involved in clinical research at the University of Hawaii Cancer Center.